Angiotensinogen as a Predictive Biomarker for AKI and CKD After AMI: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Pruritus in hemodialysis patients reduces health-related quality of life: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
SGLT2 Inhibitors Reduce CKD Progression Across All Kidney Function Levels: JAMA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Excessive Screen Time Linked to Early Kidney Damage in Teens, suggests research We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Radiofrequency Renal Denervation effective on long term basis among Patients With and Without CKD: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Autosomal Dominant Polycystic Kidney Disease Associated with Better Dialysis Survival: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Medical Bulletin 10/November/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
India Ranks Second Globally With 138 Million Kidney Disease Cases in 2023: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Sarcopenia Emerges as Strong Predictor of Mortality in Cardiovascular-Kidney-Metabolic Syndrome: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Drug firm Bayer on Thursday said it has received approval for its innovative therapy Kerendia for the treatment of heart failure from the Indian regulatory authorities. The product (finerenone) is already approved for chronic kidney disease (CKD) associated with type 2 diabetes (T2D). “With the expansion of finerenone’s indication, we are addressing types of heart…